Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BAXTER INTERNATIONAL INCBAX · Entity 1707 | SVP, President, Americas | February 28, 2019 | March 04, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BAXTER INTERNATIONAL INC
Report date February 28, 2019 · Filed March 04, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $74.73 · Expires 2029-02-28 | Direct | 68,587 |
Reported balance
After 2019-02-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-02-28 · Grant · Acquired 68,587 · Balance 68,587 F1: The options become exercisable in three equal annual installments beginning on February 28, 2020, the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The options become exercisable in three equal annual installments beginning on February 28, 2020, the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2017 Filed Feb 23, 2017 21:28 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 1,772 | $49.96 | $88,529.12 |
DisclosureSEC source: 0001645572-17-000001 · edgar.xml · nonDerivative · entry 3 Eyre Brik V · CIK 0001645572 · CVP, Hospital Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,401 F3 · kind: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares earned in 2014, 2015 and 2016 as part of the 2014 PSUs. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:28 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001645572-17-000001 · edgar.xml · nonDerivative · entry 2 Eyre Brik V · CIK 0001645572 · CVP, Hospital Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,173 F2 · kind: Represents shares awarded from the 2014 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Growth in Shareholder Value (GSV) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's GSV during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:28 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 1,394 | $0.00 | $0.00 |
DisclosureSEC source: 0001645572-17-000001 · edgar.xml · nonDerivative · entry 1 Eyre Brik V · CIK 0001645572 · CVP, Hospital Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,475 F1 · kind: Represents shares awarded from the performance share unit award granted on March 4, 2014 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2014 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Return on Invested Capital (ROIC) performance, as assessed annually over a three-year period. One-third of the ROIC performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's ROIC during the January 1, 2016 to December 31, 2016 performance period. These shares have vested as the relevant three-year performance period January 1, 2014 to December 31, 2016 (the Three-Year Performance Period) has ended. Read SEC document |
| December 02, 2016 Filed Dec 6, 2016 21:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 295 | $44.01 | $12,982.95 |
DisclosureSEC source: 0001645572-16-000007 · edgar.xml · nonDerivative · entry 2 Eyre Brik V · CIK 0001645572 · CVP, Hospital Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,889 F2 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on December 2, 2013. Read SEC document |
| December 02, 2016 Filed Dec 6, 2016 21:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 1,226 | $44.01 | $53,956.26 |
DisclosureSEC source: 0001645572-16-000007 · edgar.xml · nonDerivative · entry 1 Eyre Brik V · CIK 0001645572 · CVP, Hospital Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,184 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock granted on December 2, 2013. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.